These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 15170013)
1. Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities. Vandebosch A; Goetghebeur E; Ramjee G; Alary M; Ettiègne-Traoré V; Chandeying V; Van Damme L; Sex Transm Infect; 2004 Jun; 80(3):241-3. PubMed ID: 15170013 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Van Damme L; Ramjee G; Alary M; Vuylsteke B; Chandeying V; Rees H; Sirivongrangson P; Mukenge-Tshibaka L; Ettiègne-Traoré V; Uaheowitchai C; Karim SS; Mâsse B; Perriëns J; Laga M; Lancet; 2002 Sep; 360(9338):971-7. PubMed ID: 12383665 [TBL] [Abstract][Full Text] [Related]
3. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426 [TBL] [Abstract][Full Text] [Related]
4. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. COL-1492 Phase II Study Group. Van Damme L; Chandeying V; Ramjee G; Rees H; Sirivongrangson P; Laga M; Perriëns J AIDS; 2000 Jan; 14(1):85-8. PubMed ID: 10714571 [TBL] [Abstract][Full Text] [Related]
5. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043 [TBL] [Abstract][Full Text] [Related]
6. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. Rustomjee R; Abdool Karim Q; Abdool Karim SS; Laga M; Stein Z AIDS; 1999 Aug; 13(12):1511-5. PubMed ID: 10465075 [TBL] [Abstract][Full Text] [Related]
7. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa. Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545 [No Abstract] [Full Text] [Related]
8. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603 [TBL] [Abstract][Full Text] [Related]
9. Acceptability of five nonoxynol-9 spermicides. Raymond EG; Chen PL; Condon S; Luoto J; Barnhart KT; Creinin MD; Poindexter A; Wan L; Martens M; Schenken R; Blackwell R Contraception; 2005 Jun; 71(6):438-42. PubMed ID: 15914133 [TBL] [Abstract][Full Text] [Related]
10. Acceptability and feasibility of a clinical trial to assess the efficacy of a microbicide-containing vaginal gel to prevent HIV infection among female sex workers in Abidjan, Côte d'Ivoire. Ettiègne-Traoré V; Ghys PD; Van Damme L; N'Krumah M; Maïga A; Tiémelé A; Mah-bi G; Coulibaly IM; Laga M; Greenberg AE AIDS; 1997 Nov; 11(13):1660-2. PubMed ID: 9365779 [No Abstract] [Full Text] [Related]
11. Duration of vaginal retention and potential duration of antiviral activity for five nonoxynol-9 containing intravaginal contraceptives. Witter FR; Barditch-Crovo P; Rocco L; Trapnell CB Int J Gynaecol Obstet; 1999 May; 65(2):165-70. PubMed ID: 10405061 [TBL] [Abstract][Full Text] [Related]
12. Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. A randomized clinical trial. Martin HL; Stevens CE; Richardson BA; Rugamba D; Nyange PM; Mandaliya K; Ndinya-Achola J; Kreiss JK Sex Transm Dis; 1997 May; 24(5):279-83. PubMed ID: 9153737 [TBL] [Abstract][Full Text] [Related]
13. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Hira SK; Feldblum PJ; Kamanga J; Mukelabai G; Weir SS; Thomas JC Int J STD AIDS; 1997 Apr; 8(4):243-50. PubMed ID: 9147157 [TBL] [Abstract][Full Text] [Related]
14. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. Van Damme L; Niruthisard S; Atisook R; Boer K; Dally L; Laga M; Lange JM; Karam M; Perriens JH AIDS; 1998 Mar; 12(4):433-7. PubMed ID: 9520174 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women. Li W; Huang Z; Wu Y; Wang H; Zhou X; Xiao Z; Ding X; Xu J Contraception; 2013 Jun; 87(6):756-65. PubMed ID: 23089047 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133 [TBL] [Abstract][Full Text] [Related]
17. AIDS chief says nonoxynol-9 not effective against HIV. AIDS Wkly; 2000 Jul 10-17; ():2-3. PubMed ID: 12296062 [TBL] [Abstract][Full Text] [Related]
18. Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection. Visness CM; Ulin P; Pfannenschmidt S; Zekeng L Int J STD AIDS; 1998 Nov; 9(11):695-9. PubMed ID: 9863584 [TBL] [Abstract][Full Text] [Related]
19. [Current status of the female condom in Africa]. Deniaud F Sante; 1997; 7(6):405-15. PubMed ID: 9503499 [TBL] [Abstract][Full Text] [Related]
20. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Weir SS; Roddy RE; Zekeng L; Feldblum PJ Genitourin Med; 1995 Apr; 71(2):78-81. PubMed ID: 7744418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]